Applied DNA Reports Fiscal Second Quarter 2019 Financial Results

Go back to Applied DNA Reports Fiscal Second Quarter 2019 Financial Results

Applied DNA Sciences (APDN) Tops Q2 EPS by 1c

May 9, 2019 4:11 PM EDT

Applied DNA Sciences (NASDAQ: APDN) reported Q2 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $778 thousand versus the consensus estimate of $1.32 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.

... More